NO20061575L - Fremgangsmate for fremstilling av renzapride og mellomprodukter derav - Google Patents

Fremgangsmate for fremstilling av renzapride og mellomprodukter derav

Info

Publication number: NO20061575L
Authority: NO; Norway
Prior art keywords: intermediates; preparation; renzapride; azabicyclo; endo
Prior art date: 2003-09-09

Application number

NO20061575A

Other languages

English (en)

Norwegian (no)

Inventor

John Knight

Richard Michael John Palmer

Nicholas Leslie Meyers

Original Assignee

Alizyme Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-09

Filing date

2006-04-07

Publication date

2006-06-09

2006-04-07 Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd

2006-06-09 Publication of NO20061575L publication Critical patent/NO20061575L/no

Links

239000000543 intermediate Substances 0.000 title abstract 2
GZSKEXSLDPEFPT-IINYFYTJSA-N renzapride Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)N[C@H]1[C@H](C2)CCC[N@]2CC1 GZSKEXSLDPEFPT-IINYFYTJSA-N 0.000 title 1
229950003039 renzapride Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

NO20061575A 2003-09-09 2006-04-07 Fremgangsmate for fremstilling av renzapride og mellomprodukter derav NO20061575L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0321091.1A GB0321091D0 (en)	2003-09-09	2003-09-09	Synthesis
PCT/GB2004/003820 WO2005023808A2 (en)	2003-09-09	2004-09-06	Process for the preparation of renzapride and intermediates thereof

Publications (1)

Publication Number	Publication Date
NO20061575L true NO20061575L (no)	2006-06-09

Family

ID=29226752

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061575A NO20061575L (no)	2003-09-09	2006-04-07	Fremgangsmate for fremstilling av renzapride og mellomprodukter derav

Country Status (17)

Country	Link
US (2)	US7189852B2 (pt)
EP (1)	EP1664048A2 (pt)
JP (1)	JP2007505089A (pt)
KR (1)	KR20060092211A (pt)
CN (1)	CN1849320A (pt)
AR (1)	AR045625A1 (pt)
AU (1)	AU2004270465A1 (pt)
BR (1)	BRPI0414200A (pt)
CA (1)	CA2537536A1 (pt)
EA (1)	EA200600563A1 (pt)
GB (1)	GB0321091D0 (pt)
IL (1)	IL173736A0 (pt)
MX (1)	MXPA06002743A (pt)
NO (1)	NO20061575L (pt)
TW (1)	TW200526661A (pt)
WO (1)	WO2005023808A2 (pt)
ZA (1)	ZA200601991B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7811707B2 (en) *	2004-12-28	2010-10-12	Boston-Power, Inc.	Lithium-ion secondary battery
US20080008933A1 (en) *	2005-12-23	2008-01-10	Boston-Power, Inc.	Lithium-ion secondary battery
TWI426678B (zh) *	2006-06-28	2014-02-11	波士頓電力公司	具有多重充電率之電子裝置、電池組、充電於電子裝置中的鋰離子電荷儲存電源供應器之方法及可攜式電腦
US20090297937A1 (en) *	2008-04-24	2009-12-03	Lampe-Onnerud Christina M	Lithium-ion secondary battery
WO2010030875A1 (en) *	2008-09-12	2010-03-18	Boston-Power, Inc.	Method and apparatus for embedded battery cells and thermal management
CN102422504A (zh) *	2009-05-18	2012-04-18	波士顿电力公司	可充电电池的能量效率及快速充电模式
WO2011028703A2 (en) *	2009-09-01	2011-03-10	Boston-Power, Inc.	Safety and performance optimized controls for large scale electric vehicle battery systems
WO2011028695A2 (en) *	2009-09-01	2011-03-10	Boston-Power, Inc.	Large scale battery systems and method of assembly
WO2019018219A1 (en)	2017-07-21	2019-01-24	Rohm And Haas Company	POLY RESIN COMPOSITION (METHYL METHACRYLATE)
CN114286813A (zh) *	2019-08-29	2022-04-05	詹森生物科技公司	取代的脲二氢乳清酸脱氢酶抑制剂
CN112094239A (zh) *	2020-11-03	2020-12-18	燃点(南京)生物医药科技有限公司	一种乌拉地尔杂质化合物、制备方法及其应用
CN113773219B (zh) *	2021-09-30	2024-08-13	内蒙古康普药业有限公司	一种甲氧氯普胺双氯杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5010573B1 (pt) *	1970-04-24	1975-04-22
DE2119724B2 (de)	1970-04-24	1976-04-29	Teikoku Hormone Manufacturing Co. Ltd., Tokio	Verfahren zur herstellung einer halogensubstituierten benzoesaeure
CA1223873A (en)	1982-04-14	1987-07-07	Francis D. King	Pharmaceutically active compounds
ZA832549B (en) *	1982-04-14	1988-09-28	Beecham Group Plc	Pharmaceutically active compounds
GB8523211D0 (en) *	1985-09-19	1985-10-23	Beecham Group Plc	Compounds
GB8607163D0 (en) *	1986-03-22	1986-04-30	Beecham Group Plc	Chemical compound
US5330982A (en) *	1986-12-17	1994-07-19	Glaxo Group Limited	Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
US5140023A (en)	1990-04-27	1992-08-18	G. D. Searle & Co.	Azatetracycle compounds
EP0749966A4 (en)	1994-03-11	1997-07-02	Yamanouchi Pharma Co Ltd	5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT
GB0329319D0 (en) *	2003-12-18	2004-01-21	Alizyme Therapeutics Ltd	Synthesis

2003
- 2003-09-09 GB GBGB0321091.1A patent/GB0321091D0/en not_active Ceased
2004
- 2004-07-02 US US10/884,842 patent/US7189852B2/en not_active Expired - Lifetime
- 2004-09-02 TW TW093126521A patent/TW200526661A/zh unknown
- 2004-09-06 EP EP04768367A patent/EP1664048A2/en not_active Withdrawn
- 2004-09-06 MX MXPA06002743A patent/MXPA06002743A/es unknown
- 2004-09-06 EA EA200600563A patent/EA200600563A1/ru unknown
- 2004-09-06 WO PCT/GB2004/003820 patent/WO2005023808A2/en not_active Ceased
- 2004-09-06 KR KR1020067004708A patent/KR20060092211A/ko not_active Withdrawn
- 2004-09-06 AU AU2004270465A patent/AU2004270465A1/en not_active Abandoned
- 2004-09-06 CA CA002537536A patent/CA2537536A1/en not_active Abandoned
- 2004-09-06 BR BRPI0414200-4A patent/BRPI0414200A/pt not_active IP Right Cessation
- 2004-09-06 JP JP2006525881A patent/JP2007505089A/ja active Pending
- 2004-09-06 CN CNA2004800259716A patent/CN1849320A/zh active Pending
- 2004-09-09 AR ARP040103240A patent/AR045625A1/es not_active Application Discontinuation
2006
- 2006-02-14 IL IL173736A patent/IL173736A0/en unknown
- 2006-03-08 ZA ZA200601991A patent/ZA200601991B/xx unknown
- 2006-04-07 NO NO20061575A patent/NO20061575L/no not_active Application Discontinuation
2007
- 2007-01-08 US US11/650,740 patent/US20070135641A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA06002743A (es)	2006-06-05
BRPI0414200A (pt)	2006-10-31
CA2537536A1 (en)	2005-03-17
AU2004270465A1 (en)	2005-03-17
JP2007505089A (ja)	2007-03-08
TW200526661A (en)	2005-08-16
WO2005023808A2 (en)	2005-03-17
EP1664048A2 (en)	2006-06-07
ZA200601991B (en)	2009-08-26
US20050049416A1 (en)	2005-03-03
KR20060092211A (ko)	2006-08-22
AR045625A1 (es)	2005-11-02
IL173736A0 (en)	2006-07-05
US20070135641A1 (en)	2007-06-14
GB0321091D0 (en)	2003-10-08
US7189852B2 (en)	2007-03-13
WO2005023808A3 (en)	2005-07-07
CN1849320A (zh)	2006-10-18
EA200600563A1 (ru)	2006-12-29

Similar Documents

Publication	Publication Date	Title
EE04911B1 (et)	2007-10-15	Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
MXPA02012712A (es)	2003-04-25	N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2005013892A3 (en)	2005-06-16	Hydrolytically-resistant boron-containing therapeutics and methods of use
EP1485381B8 (en)	2010-05-12	Azolylaminoazine as inhibitors of protein kinases
TR200101859T2 (tr)	2001-12-21	Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
AU2003220299A1 (en)	2003-09-29	Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en)	2003-09-29	Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en)	2003-09-29	Compositions useful as inhibitors of protein kinases
ATE284690T1 (de)	2005-01-15	Antithrombotische diamine
MXPA03011515A (es)	2004-03-18	Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
PT1656345E (pt)	2013-12-27	Derivados cíclicos como moduladores da actividade de receptores de quimioquinas
WO2003024401A3 (en)	2003-12-18	Piperizinones as modulators of chemokine receptor activity
MXPA05010440A (es)	2005-11-04	Amidas del acido isoquinolina-5-sulfonico como inhibidores de la akt (proteina quinasa b).
TW200716583A (en)	2007-05-01	Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
NO20061575L (no)	2006-06-09	Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
WO2001068645A3 (en)	2002-03-07	N-cyanomethylcarboxamides and their use as protease inhibitors
MXPA03010766A (es)	2005-03-07	Nuevos compuestos y composiciones como inhibicores de las catepsinas.
MXPA04005151A (es)	2004-08-11	Compuestos terapeuticos.
WO2005048932A3 (en)	2006-09-14	N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
TW200512189A (en)	2005-04-01	Cyclic derivatives as modulators of chemokine receptor activity
SE0100295D0 (sv)	2001-02-01	New compounds
WO2006009907A3 (en)	2006-11-23	Isoxazolidine compounds for treatment of bacterial infections
NO20063299L (no)	2006-07-17	Syntese av en polymorf av 4-amino-5-klor-2-metoksy-N-(1-azabisyklo[3.3.1]non-4-yl)benzamidhydrokloridhydrat

Legal Events

Date	Code	Title	Description
2009-04-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application